Citius Pharmaceuticals In... (CTXR)

CTXR trades at $1.37, 37.0% above the near-term max pain of $1 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$350), reflecting growing call interest at higher strikes. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for CTXR shows an upward trend from 1 to 350, suggesting bullish positioning in longer-dated options. The 492% spread signals divergent expectations across timeframes. Levels distributed around 1.37. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.